Literature DB >> 27556289

Mechanism of PAMAM Dendrimers Internalization in Hippocampal Neurons.

Felipe Vidal1, Pilar Vásquez1, Carola Díaz2, Daniela Nova1, Joel Alderete2, Leonardo Guzmán1.   

Abstract

Polyamidoamine (PAMAM) dendrimers are hyperbranched macromolecules which have been described as one of the most promising drug nanocarrier systems. A key process to understand is their cellular internalization mechanism because of its direct influence on their intracellular distribution, association with organelles, entry kinetics, and cargo release. Despite that internalization mechanisms of dendrimers have been studied in different cell types, in the case of neurons they are not completely described. Considering the relevance of central nervous system (CNS) diseases and neuropharmacology, the aim of this report is to describe the molecular internalization mechanism of different PAMAM-based dendrimer systems in hippocampal neurons. Four dendrimers based on fourth generation PAMAM with different surface properties were studied: unmodified G4, with a positively charged surface; PP50, with a substitution of the 50% of amino surface groups with polyethylene glycol neutral groups; PAc, with a substitution of the 30% of amino surface groups with acrylate anionic groups; and PFO, decorated with folic acid groups in a 25% of total terminal groups. Confocal images show that both G4 and PFO are able to enter the neurons, but not PP50 and PAc. Colocalization study with specific endocytosis markers and specific endocytosis inhibitor assay demonstrate that clathrin-mediated endocytosis would be the main internalization mechanism for G4, whereas clathrin- and caveolae-mediated endocytosis would be implicated in PFO internalization. These results show the existence of different internalization mechanisms for PAMAM dendrimers in neurons and the possibility to control their internalization properties with specific chemical modifications.

Entities:  

Keywords:  PAMAM internalization; dendrimer; endocytosis; neuronal uptake; surface modification

Mesh:

Substances:

Year:  2016        PMID: 27556289     DOI: 10.1021/acs.molpharmaceut.6b00381

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  9 in total

1.  Generation-6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model.

Authors:  Fan Zhang; J Trent Magruder; Yi-An Lin; Todd C Crawford; Joshua C Grimm; Christopher M Sciortino; Mary Ann Wilson; Mary E Blue; Sujatha Kannan; Michael V Johnston; William A Baumgartner; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2017-01-27       Impact factor: 9.776

Review 2.  Overcoming barriers in non-viral gene delivery for neurological applications.

Authors:  Aaron Tasset; Arjun Bellamkonda; Wenliang Wang; Ilya Pyatnitskiy; Deidra Ward; Nicholas Peppas; Huiliang Wang
Journal:  Nanoscale       Date:  2022-03-10       Impact factor: 8.307

3.  Surface-Modified G4 PAMAM Dendrimers Cross the Blood-Brain Barrier Following Multiple Tail-Vein Injections in C57BL/6J Mice.

Authors:  Bhairavi Srinageshwar; Anthony Dils; John Sturgis; Anna Wedster; Balachandar Kathirvelu; Stephanie Baiyasi; Douglas Swanson; Ajit Sharma; Gary L Dunbar; Julien Rossignol
Journal:  ACS Chem Neurosci       Date:  2019-08-20       Impact factor: 5.780

4.  Prevention of Synaptic Alterations and Neurotoxic Effects of PAMAM Dendrimers by Surface Functionalization.

Authors:  Felipe Vidal; Pilar Vásquez; Francisca R Cayumán; Carola Díaz; Jorge Fuentealba; Luis G Aguayo; Gonzalo E Yévenes; Joel Alderete; Leonardo Guzmán
Journal:  Nanomaterials (Basel)       Date:  2017-12-25       Impact factor: 5.076

5.  The agglomeration state of nanoparticles can influence the mechanism of their cellular internalisation.

Authors:  Blanka Halamoda-Kenzaoui; Mara Ceridono; Patricia Urbán; Alessia Bogni; Jessica Ponti; Sabrina Gioria; Agnieszka Kinsner-Ovaskainen
Journal:  J Nanobiotechnology       Date:  2017-06-26       Impact factor: 10.435

Review 6.  Use of Polyamidoamine Dendrimers in Brain Diseases.

Authors:  Maria Florendo; Alexander Figacz; Bhairavi Srinageshwar; Ajit Sharma; Douglas Swanson; Gary L Dunbar; Julien Rossignol
Journal:  Molecules       Date:  2018-09-03       Impact factor: 4.411

7.  Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas.

Authors:  Changliang Liu; Zijian Zhao; Houqian Gao; Iman Rostami; Qing You; Xinru Jia; Chen Wang; Ling Zhu; Yanlian Yang
Journal:  Nanotheranostics       Date:  2019-09-19

Review 8.  Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell.

Authors:  Darío Manzanares; Valentín Ceña
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

Review 9.  Cytotoxicity of Dendrimers.

Authors:  Anna Janaszewska; Joanna Lazniewska; Przemysław Trzepiński; Monika Marcinkowska; Barbara Klajnert-Maculewicz
Journal:  Biomolecules       Date:  2019-08-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.